Investigation of Igf-1, Igf-Bp3 and Igf-Bp5 Levels in Umbilical Cord Blood of Infants with Developmental Dysplasia of the Hip

Overview

Journal Turk J Med Sci

Specialty General Medicine

Date 2023 Jul 21

PMID 37476901

Authors

Esra Demirel

Eyup Senocak

Gamze Nur Cimilli Senocak

Ali Sahin

Berrin Goktug Kadioglu

Ozlem Gunduz

Affiliations

Soon will be listed here.

Abstract

Background: IGF-1 (insulin-like growth factor-1) is an important regulator of bone formation. Its deficiency has been associated with fetal growth disorders and hip dysplasia. The aim of this study was to evaluate whether IGF-1, IGF-BP3 (insulin like growth factorbinding protein 3), and IGF-BP5 levels in the umbilical cord blood can be predictive for early diagnosis of DDH.

Methods: Umbilical cord blood samples were collected from 860 mothers with pregnancies at high risk for DDH between October 2020 and January 2021. Mothers at 37-42 weeks of gestation, with risk factors for DDH, who delivered healthy infants were included. Blood samples were collected during delivery. Each eligible infant was medically followed up and underwent a hip ultrasound in the postnatal 2nd or 3rd month. Infants diagnosed with DDH were matched with a healthy cohort in terms of sex, birth weight, maternal age, and gestational week, and the IGF-1, IGF-BP3 and IGF-BP5 levels were studied and compared.

Results: Evaluation was made of 20 infants diagnosed with DDH and 60 healthy infants. Of the total 80 infants, 72.5% were female.The umbilical cord blood levels of IGF-1 and IGF-BP3 were similar in both groups. The IGF-BP5 values were significantly lower in the DDH patient group. Except for DDH diagnosis, the other categorical variables of the study did not appear to influence the levels of any of the IGFs.

Discussion: Umbilical blood samples could potentially help diagnose DDH. The levels of IGF-BP5 were shown to be significantly lower in infants with DDH.

References

Azzopardi T, van Essen P, Cundy P, Tucker G, Chan A . Late diagnosis of developmental dysplasia of the hip: an analysis of risk factors. J Pediatr Orthop B. 2010; 20(1):1-7. DOI: 10.1097/BPB.0b013e3283415927. View

Kotlarsky P, Haber R, Bialik V, Eidelman M . Developmental dysplasia of the hip: What has changed in the last 20 years?. World J Orthop. 2015; 6(11):886-901. PMC: 4686436. DOI: 10.5312/wjo.v6.i11.886. View

Ong K, Langkamp M, Ranke M, Whitehead K, Hughes I, Acerini C . Insulin-like growth factor I concentrations in infancy predict differential gains in body length and adiposity: the Cambridge Baby Growth Study. Am J Clin Nutr. 2009; 90(1):156-61. DOI: 10.3945/ajcn.2008.27408. View

Takatani T, Shiohama T, Takatani R, Shimojo N . A novel mutation in a Japanese patient with 3M syndrome. Hum Genome Var. 2018; 5:30. PMC: 6199316. DOI: 10.1038/s41439-018-0029-3. View

McQueeney K, Dealy C . Roles of insulin-like growth factor-I (IGF-I) and IGF-I binding protein-2 (IGFBP2) and -5 (IGFBP5) in developing chick limbs. Growth Horm IGF Res. 2002; 11(6):346-63. DOI: 10.1054/ghir.2001.0250. View

Subasi I, Veizi E, Cepni S, Alkan H, Oguz T, Firat A . Clinical Examination Findings Can Accurately Diagnose Developmental Dysplasia of The Hip-A Large, Single-Center Cohort. Children (Basel). 2023; 10(2). PMC: 9954844. DOI: 10.3390/children10020304. View

Kiepe D, Ciarmatori S, Haarmann A, Tonshoff B . Differential expression of IGF system components in proliferating vs. differentiating growth plate chondrocytes: the functional role of IGFBP-5. Am J Physiol Endocrinol Metab. 2005; 290(2):E363-71. DOI: 10.1152/ajpendo.00363.2005. View

Kyung B, Lee S, Jeong W, Park S . Disparity between Clinical and Ultrasound Examinations in Neonatal Hip Screening. Clin Orthop Surg. 2016; 8(2):203-9. PMC: 4870325. DOI: 10.4055/cios.2016.8.2.203. View

Parker E, Hegde A, Buckley M, Barnes K, Baron J, Nilsson O . Spatial and temporal regulation of GH-IGF-related gene expression in growth plate cartilage. J Endocrinol. 2007; 194(1):31-40. DOI: 10.1677/JOE-07-0012. View

10.

Terjesen T . Residual hip dysplasia as a risk factor for osteoarthritis in 45 years follow-up of late-detected hip dislocation. J Child Orthop. 2012; 5(6):425-31. PMC: 3221757. DOI: 10.1007/s11832-011-0370-2. View

11.

Muller E, Dunstheimer D, Klammt J, Friebe D, Kiess W, Kratzsch J . Clinical and functional characterization of a patient carrying a compound heterozygous pericentrin mutation and a heterozygous IGF1 receptor mutation. PLoS One. 2012; 7(5):e38220. PMC: 3365032. DOI: 10.1371/journal.pone.0038220. View

12.

Andress D, Birnbaum R . Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem. 1992; 267(31):22467-72. View

13.

Lim C, Cho T, Shin C, Choi I, Yoo W . Functional Outcomes of Hip Arthroscopy for Pediatric and Adolescent Hip Disorders. Clin Orthop Surg. 2020; 12(1):94-99. PMC: 7031430. DOI: 10.4055/cios.2020.12.1.94. View

14.

Agrogiannis G, Sifakis S, Patsouris E, Konstantinidou A . Insulin-like growth factors in embryonic and fetal growth and skeletal development (Review). Mol Med Rep. 2014; 10(2):579-84. PMC: 4094767. DOI: 10.3892/mmr.2014.2258. View

15.

Saygun I, Karacay S, Serdar M, Ural A, Sencimen M, Kurtis B . Effects of laser irradiation on the release of basic fibroblast growth factor (bFGF), insulin like growth factor-1 (IGF-1), and receptor of IGF-1 (IGFBP3) from gingival fibroblasts. Lasers Med Sci. 2007; 23(2):211-5. DOI: 10.1007/s10103-007-0477-3. View

16.

Paton R . Screening in Developmental Dysplasia of the Hip (DDH). Surgeon. 2017; 15(5):290-296. DOI: 10.1016/j.surge.2017.05.002. View

17.

Chen Y, Li L, Wang E, Zhang L, Zhao Q . Abnormal expression of Pappa2 gene may indirectly affect mouse hip development through the IGF signaling pathway. Endocrine. 2019; 65(2):440-450. DOI: 10.1007/s12020-019-01975-0. View

18.

Bicici V, Bingol I, Sazak T . Mid-term results of total hip arthroplasty with subtrochanteric Z-osteotomy in Crowe type 3-4 developmental hip dysplasia. Turk J Med Sci. 2021; 51(4):1976-1983. PMC: 8569767. DOI: 10.3906/sag-2102-217. View

19.

Soran N, Altindag O, Aksoy N, Cakir H, Taskin A, Soran M . The association of serum prolidase activity with developmental dysplasia of the hip. Rheumatol Int. 2013; 33(8):1939-42. PMC: 3718991. DOI: 10.1007/s00296-013-2672-9. View

20.

DiPrisco B, Kumar A, Kalra B, Savjani G, Michael Z, Farr O . Placental proteases PAPP-A and PAPP-A2, the binding proteins they cleave (IGFBP-4 and -5), and IGF-I and IGF-II: Levels in umbilical cord blood and associations with birth weight and length. Metabolism. 2019; 100:153959. DOI: 10.1016/j.metabol.2019.153959. View